カテゴリー： LP Information, 世界, 医療/バイオ

世界の肺薬物送達装置市場予測 2023年-2029年

◆英語タイトル：Global Pulmonary Drug Delivery Devices Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU0230）◆商品コード：LP23JU0230
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月（※2025年版があります。お問い合わせください。）
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の肺薬物送達装置市場」は、過去の販売実績から2022年の世界の肺薬物送達装置の総販売量を検討し、2023年から2029年の予測される肺薬物送達装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の肺薬物送達装置の市場規模を掲載し、XXX百万米ドル規模の世界の肺薬物送達装置市場の詳細な分析を提供します。本インサイトレポートは、世界の肺薬物送達装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の肺薬物送達装置市場における各社の独自のポジションをより深く理解するために、肺薬物送達装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の肺薬物送達装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。肺薬物送達装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。肺薬物送達装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。肺薬物送達装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

肺薬物送達装置の世界主要メーカーとしては、Boehringer Ingelheim GmbH、 Novartis AG、 GlaxoSmithKline、 AstraZeneca、 Teva Pharmaceutical Industries、 Merck、 MannKind、 Bristol-Myers Squibb、 Mylan N.V、 Omron Corp、 F. Hoffmann-La Roche、 3M Healthcare、 Sunovion Pharmaceuticals、 Koninklijke Philips N.V、 Gerresheimer AG、 Bespak、 AptarGroup、 SHL Group、 Nypro Healthcare、 Hovione、 Chiesi Farmaceutici S.P.Aなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の肺薬物送達装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では肺薬物送達装置市場をセグメンテーションし、種類別 (ドライパウダー吸入器、定量吸入器、ネブライザー)、用途別 (喘息、COPD、嚢胞性線維症、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ドライパウダー吸入器、定量吸入器、ネブライザー

・用途別区分：喘息、COPD、嚢胞性線維症、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の肺薬物送達装置市場の10年間の市場状況・展望は？
・世界および地域別に見た肺薬物送達装置市場成長の要因は何か？
・肺薬物送達装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・肺薬物送達装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：肺薬物送達装置の年間販売量2018-2029、地域別現状・将来分析
・肺薬物送達装置の種類別セグメント：ドライパウダー吸入器、定量吸入器、ネブライザー
・肺薬物送達装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・肺薬物送達装置の用途別セグメント：喘息、COPD、嚢胞性線維症、その他
・肺薬物送達装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の肺薬物送達装置市場
・企業別のグローバル肺薬物送達装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の肺薬物送達装置の年間売上：2018-2023年の売上、市場シェア
・企業別の肺薬物送達装置販売価格
・主要企業の肺薬物送達装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

肺薬物送達装置の地域別レビュー
・地域別の肺薬物送達装置市場規模2018-2023：年間販売量、売上
・主要国別の肺薬物送達装置市場規模2018-2023：年間販売量、売上
・南北アメリカの肺薬物送達装置販売の成長
・アジア太平洋の肺薬物送達装置販売の成長
・ヨーロッパの肺薬物送達装置販売の成長
・中東・アフリカの肺薬物送達装置販売の成長

南北アメリカ市場
・南北アメリカの国別の肺薬物送達装置販売量、売上（2018-2023）
・南北アメリカの肺薬物送達装置の種類別販売量
・南北アメリカの肺薬物送達装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の肺薬物送達装置販売量、売上（2018-2023）
・アジア太平洋の肺薬物送達装置の種類別販売量
・アジア太平洋の肺薬物送達装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の肺薬物送達装置販売量、売上（2018-2023）
・ヨーロッパの肺薬物送達装置の種類別販売量
・ヨーロッパの肺薬物送達装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の肺薬物送達装置販売量、売上（2018-2023）
・中東・アフリカの肺薬物送達装置の種類別販売量
・中東・アフリカの肺薬物送達装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・肺薬物送達装置の製造コスト構造分析
・肺薬物送達装置の製造プロセス分析
・肺薬物送達装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・肺薬物送達装置の主要なグローバル販売業者
・肺薬物送達装置の主要なグローバル顧客

地域別の肺薬物送達装置市場予測レビュー
・地域別の肺薬物送達装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・肺薬物送達装置の種類別市場規模予測
・肺薬物送達装置の用途別市場規模予測

主要企業分析
Boehringer Ingelheim GmbH、 Novartis AG、 GlaxoSmithKline、 AstraZeneca、 Teva Pharmaceutical Industries、 Merck、 MannKind、 Bristol-Myers Squibb、 Mylan N.V、 Omron Corp、 F. Hoffmann-La Roche、 3M Healthcare、 Sunovion Pharmaceuticals、 Koninklijke Philips N.V、 Gerresheimer AG、 Bespak、 AptarGroup、 SHL Group、 Nypro Healthcare、 Hovione、 Chiesi Farmaceutici S.P.A
・企業情報
・肺薬物送達装置製品
・肺薬物送達装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Pulmonary Drug Delivery Devices Industry Forecast” looks at past sales and reviews total world Pulmonary Drug Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Pulmonary Drug Delivery Devices sales for 2023 through 2029. With Pulmonary Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Drug Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pulmonary Drug Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Drug Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Drug Delivery Devices.
The global Pulmonary Drug Delivery Devices market size is projected to grow from US$ 2773.9 million in 2022 to US$ 3738.9 million in 2029; it is expected to grow at a CAGR of 3738.9 from 2023 to 2029.
United States market for Pulmonary Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pulmonary Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pulmonary Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pulmonary Drug Delivery Devices players cover Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb and Mylan N.V, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Segmentation by application
Asthma
COPD
Cystic Fibrosis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pulmonary Drug Delivery Devices market?
What factors are driving Pulmonary Drug Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Drug Delivery Devices market opportunities vary by end market size?
How does Pulmonary Drug Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pulmonary Drug Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pulmonary Drug Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pulmonary Drug Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Pulmonary Drug Delivery Devices Segment by Type
2.2.1 Dry Powder Inhaler
2.2.2 Metered Dose Inhaler
2.2.3 Nebulizer
2.3 Pulmonary Drug Delivery Devices Sales by Type
2.3.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pulmonary Drug Delivery Devices Sale Price by Type (2018-2023)
2.4 Pulmonary Drug Delivery Devices Segment by Application
2.4.1 Asthma
2.4.2 COPD
2.4.3 Cystic Fibrosis
2.4.4 Other
2.5 Pulmonary Drug Delivery Devices Sales by Application
2.5.1 Global Pulmonary Drug Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pulmonary Drug Delivery Devices Sale Price by Application (2018-2023)
3 Global Pulmonary Drug Delivery Devices by Company
3.1 Global Pulmonary Drug Delivery Devices Breakdown Data by Company
3.1.1 Global Pulmonary Drug Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Pulmonary Drug Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Pulmonary Drug Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Pulmonary Drug Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Pulmonary Drug Delivery Devices Sale Price by Company
3.4 Key Manufacturers Pulmonary Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Drug Delivery Devices Product Location Distribution
3.4.2 Players Pulmonary Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pulmonary Drug Delivery Devices by Geographic Region
4.1 World Historic Pulmonary Drug Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Pulmonary Drug Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pulmonary Drug Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pulmonary Drug Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Pulmonary Drug Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pulmonary Drug Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pulmonary Drug Delivery Devices Sales Growth
4.4 APAC Pulmonary Drug Delivery Devices Sales Growth
4.5 Europe Pulmonary Drug Delivery Devices Sales Growth
4.6 Middle East & Africa Pulmonary Drug Delivery Devices Sales Growth
5 Americas
5.1 Americas Pulmonary Drug Delivery Devices Sales by Country
5.1.1 Americas Pulmonary Drug Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Pulmonary Drug Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Pulmonary Drug Delivery Devices Sales by Type
5.3 Americas Pulmonary Drug Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Drug Delivery Devices Sales by Region
6.1.1 APAC Pulmonary Drug Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Pulmonary Drug Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Pulmonary Drug Delivery Devices Sales by Type
6.3 APAC Pulmonary Drug Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pulmonary Drug Delivery Devices by Country
7.1.1 Europe Pulmonary Drug Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Pulmonary Drug Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Pulmonary Drug Delivery Devices Sales by Type
7.3 Europe Pulmonary Drug Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pulmonary Drug Delivery Devices by Country
8.1.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type
8.3 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices
10.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
10.4 Industry Chain Structure of Pulmonary Drug Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Drug Delivery Devices Distributors
11.3 Pulmonary Drug Delivery Devices Customer
12 World Forecast Review for Pulmonary Drug Delivery Devices by Geographic Region
12.1 Global Pulmonary Drug Delivery Devices Market Size Forecast by Region
12.1.1 Global Pulmonary Drug Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Pulmonary Drug Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pulmonary Drug Delivery Devices Forecast by Type
12.7 Global Pulmonary Drug Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim GmbH
13.1.1 Boehringer Ingelheim GmbH Company Information
13.1.2 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim GmbH Main Business Overview
13.1.5 Boehringer Ingelheim GmbH Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Information
13.5.2 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Industries Main Business Overview
13.5.5 Teva Pharmaceutical Industries Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 MannKind
13.7.1 MannKind Company Information
13.7.2 MannKind Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MannKind Main Business Overview
13.7.5 MannKind Latest Developments
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Information
13.8.2 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bristol-Myers Squibb Main Business Overview
13.8.5 Bristol-Myers Squibb Latest Developments
13.9 Mylan N.V
13.9.1 Mylan N.V Company Information
13.9.2 Mylan N.V Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mylan N.V Main Business Overview
13.9.5 Mylan N.V Latest Developments
13.10 Omron Corp
13.10.1 Omron Corp Company Information
13.10.2 Omron Corp Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Omron Corp Main Business Overview
13.10.5 Omron Corp Latest Developments
13.11 F. Hoffmann-La Roche
13.11.1 F. Hoffmann-La Roche Company Information
13.11.2 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 F. Hoffmann-La Roche Main Business Overview
13.11.5 F. Hoffmann-La Roche Latest Developments
13.12 3M Healthcare
13.12.1 3M Healthcare Company Information
13.12.2 3M Healthcare Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 3M Healthcare Main Business Overview
13.12.5 3M Healthcare Latest Developments
13.13 Sunovion Pharmaceuticals
13.13.1 Sunovion Pharmaceuticals Company Information
13.13.2 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sunovion Pharmaceuticals Main Business Overview
13.13.5 Sunovion Pharmaceuticals Latest Developments
13.14 Koninklijke Philips N.V
13.14.1 Koninklijke Philips N.V Company Information
13.14.2 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Koninklijke Philips N.V Main Business Overview
13.14.5 Koninklijke Philips N.V Latest Developments
13.15 Gerresheimer AG
13.15.1 Gerresheimer AG Company Information
13.15.2 Gerresheimer AG Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Gerresheimer AG Main Business Overview
13.15.5 Gerresheimer AG Latest Developments
13.16 Bespak
13.16.1 Bespak Company Information
13.16.2 Bespak Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Bespak Main Business Overview
13.16.5 Bespak Latest Developments
13.17 AptarGroup
13.17.1 AptarGroup Company Information
13.17.2 AptarGroup Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 AptarGroup Main Business Overview
13.17.5 AptarGroup Latest Developments
13.18 SHL Group
13.18.1 SHL Group Company Information
13.18.2 SHL Group Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 SHL Group Main Business Overview
13.18.5 SHL Group Latest Developments
13.19 Nypro Healthcare
13.19.1 Nypro Healthcare Company Information
13.19.2 Nypro Healthcare Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Nypro Healthcare Main Business Overview
13.19.5 Nypro Healthcare Latest Developments
13.20 Hovione
13.20.1 Hovione Company Information
13.20.2 Hovione Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Hovione Main Business Overview
13.20.5 Hovione Latest Developments
13.21 Chiesi Farmaceutici S.P.A
13.21.1 Chiesi Farmaceutici S.P.A Company Information
13.21.2 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Portfolios and Specifications
13.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Chiesi Farmaceutici S.P.A Main Business Overview
13.21.5 Chiesi Farmaceutici S.P.A Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Pulmonary Drug Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pulmonary Drug Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Dry Powder Inhaler
Table 4. Major Players of Metered Dose Inhaler
Table 5. Major Players of Nebulizer
Table 6. Global Pulmonary Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 7. Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2018-2023)
Table 8. Global Pulmonary Drug Delivery Devices Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Table 10. Global Pulmonary Drug Delivery Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Pulmonary Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 12. Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2018-2023)
Table 13. Global Pulmonary Drug Delivery Devices Revenue by Application (2018-2023)
Table 14. Global Pulmonary Drug Delivery Devices Revenue Market Share by Application (2018-2023)
Table 15. Global Pulmonary Drug Delivery Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Pulmonary Drug Delivery Devices Sales by Company (2018-2023) & (K Units)
Table 17. Global Pulmonary Drug Delivery Devices Sales Market Share by Company (2018-2023)
Table 18. Global Pulmonary Drug Delivery Devices Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pulmonary Drug Delivery Devices Revenue Market Share by Company (2018-2023)
Table 20. Global Pulmonary Drug Delivery Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Pulmonary Drug Delivery Devices Producing Area Distribution and Sales Area
Table 22. Players Pulmonary Drug Delivery Devices Products Offered
Table 23. Pulmonary Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pulmonary Drug Delivery Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Pulmonary Drug Delivery Devices Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pulmonary Drug Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pulmonary Drug Delivery Devices Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pulmonary Drug Delivery Devices Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Pulmonary Drug Delivery Devices Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pulmonary Drug Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pulmonary Drug Delivery Devices Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pulmonary Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 35. Americas Pulmonary Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 36. Americas Pulmonary Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pulmonary Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 38. Americas Pulmonary Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 39. Americas Pulmonary Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 40. APAC Pulmonary Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 41. APAC Pulmonary Drug Delivery Devices Sales Market Share by Region (2018-2023)
Table 42. APAC Pulmonary Drug Delivery Devices Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pulmonary Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Table 44. APAC Pulmonary Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 45. APAC Pulmonary Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 46. Europe Pulmonary Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 47. Europe Pulmonary Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 48. Europe Pulmonary Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 50. Europe Pulmonary Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 51. Europe Pulmonary Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Pulmonary Drug Delivery Devices
Table 59. Key Market Challenges & Risks of Pulmonary Drug Delivery Devices
Table 60. Key Industry Trends of Pulmonary Drug Delivery Devices
Table 61. Pulmonary Drug Delivery Devices Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pulmonary Drug Delivery Devices Distributors List
Table 64. Pulmonary Drug Delivery Devices Customer List
Table 65. Global Pulmonary Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Pulmonary Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pulmonary Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Pulmonary Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pulmonary Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Pulmonary Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pulmonary Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Pulmonary Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pulmonary Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pulmonary Drug Delivery Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Pulmonary Drug Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pulmonary Drug Delivery Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Pulmonary Drug Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Boehringer Ingelheim GmbH Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 81. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Boehringer Ingelheim GmbH Main Business
Table 83. Boehringer Ingelheim GmbH Latest Developments
Table 84. Novartis AG Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis AG Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 86. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Novartis AG Main Business
Table 88. Novartis AG Latest Developments
Table 89. GlaxoSmithKline Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 91. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. GlaxoSmithKline Main Business
Table 93. GlaxoSmithKline Latest Developments
Table 94. AstraZeneca Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 96. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 101. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Teva Pharmaceutical Industries Main Business
Table 103. Teva Pharmaceutical Industries Latest Developments
Table 104. Merck Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 106. Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. MannKind Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. MannKind Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 111. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. MannKind Main Business
Table 113. MannKind Latest Developments
Table 114. Bristol-Myers Squibb Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 116. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Bristol-Myers Squibb Main Business
Table 118. Bristol-Myers Squibb Latest Developments
Table 119. Mylan N.V Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Mylan N.V Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 121. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Mylan N.V Main Business
Table 123. Mylan N.V Latest Developments
Table 124. Omron Corp Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 125. Omron Corp Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 126. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Omron Corp Main Business
Table 128. Omron Corp Latest Developments
Table 129. F. Hoffmann-La Roche Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 130. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 131. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. F. Hoffmann-La Roche Main Business
Table 133. F. Hoffmann-La Roche Latest Developments
Table 134. 3M Healthcare Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 135. 3M Healthcare Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 136. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. 3M Healthcare Main Business
Table 138. 3M Healthcare Latest Developments
Table 139. Sunovion Pharmaceuticals Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 140. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 141. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Sunovion Pharmaceuticals Main Business
Table 143. Sunovion Pharmaceuticals Latest Developments
Table 144. Koninklijke Philips N.V Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 145. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 146. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Koninklijke Philips N.V Main Business
Table 148. Koninklijke Philips N.V Latest Developments
Table 149. Gerresheimer AG Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 150. Gerresheimer AG Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 151. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Gerresheimer AG Main Business
Table 153. Gerresheimer AG Latest Developments
Table 154. Bespak Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 155. Bespak Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 156. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 157. Bespak Main Business
Table 158. Bespak Latest Developments
Table 159. AptarGroup Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 160. AptarGroup Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 161. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. AptarGroup Main Business
Table 163. AptarGroup Latest Developments
Table 164. SHL Group Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 165. SHL Group Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 166. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 167. SHL Group Main Business
Table 168. SHL Group Latest Developments
Table 169. Nypro Healthcare Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 170. Nypro Healthcare Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 171. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 172. Nypro Healthcare Main Business
Table 173. Nypro Healthcare Latest Developments
Table 174. Hovione Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 175. Hovione Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 176. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 177. Hovione Main Business
Table 178. Hovione Latest Developments
Table 179. Chiesi Farmaceutici S.P.A Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 180. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Portfolios and Specifications
Table 181. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 182. Chiesi Farmaceutici S.P.A Main Business
Table 183. Chiesi Farmaceutici S.P.A Latest Developments
List of Figures
Figure 1. Picture of Pulmonary Drug Delivery Devices
Figure 2. Pulmonary Drug Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Drug Delivery Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pulmonary Drug Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pulmonary Drug Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Dry Powder Inhaler
Figure 10. Product Picture of Metered Dose Inhaler
Figure 11. Product Picture of Nebulizer
Figure 12. Global Pulmonary Drug Delivery Devices Sales Market Share by Type in 2022
Figure 13. Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Figure 14. Pulmonary Drug Delivery Devices Consumed in Asthma
Figure 15. Global Pulmonary Drug Delivery Devices Market: Asthma (2018-2023) & (K Units)
Figure 16. Pulmonary Drug Delivery Devices Consumed in COPD
Figure 17. Global Pulmonary Drug Delivery Devices Market: COPD (2018-2023) & (K Units)
Figure 18. Pulmonary Drug Delivery Devices Consumed in Cystic Fibrosis
Figure 19. Global Pulmonary Drug Delivery Devices Market: Cystic Fibrosis (2018-2023) & (K Units)
Figure 20. Pulmonary Drug Delivery Devices Consumed in Other
Figure 21. Global Pulmonary Drug Delivery Devices Market: Other (2018-2023) & (K Units)
Figure 22. Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2022)
Figure 23. Global Pulmonary Drug Delivery Devices Revenue Market Share by Application in 2022
Figure 24. Pulmonary Drug Delivery Devices Sales Market by Company in 2022 (K Units)
Figure 25. Global Pulmonary Drug Delivery Devices Sales Market Share by Company in 2022
Figure 26. Pulmonary Drug Delivery Devices Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Pulmonary Drug Delivery Devices Revenue Market Share by Company in 2022
Figure 28. Global Pulmonary Drug Delivery Devices Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Pulmonary Drug Delivery Devices Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Pulmonary Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 31. Americas Pulmonary Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 32. APAC Pulmonary Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 33. APAC Pulmonary Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 34. Europe Pulmonary Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 35. Europe Pulmonary Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Pulmonary Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Pulmonary Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 38. Americas Pulmonary Drug Delivery Devices Sales Market Share by Country in 2022
Figure 39. Americas Pulmonary Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 40. Americas Pulmonary Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 41. Americas Pulmonary Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 42. United States Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Pulmonary Drug Delivery Devices Sales Market Share by Region in 2022
Figure 47. APAC Pulmonary Drug Delivery Devices Revenue Market Share by Regions in 2022
Figure 48. APAC Pulmonary Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 49. APAC Pulmonary Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 50. China Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Pulmonary Drug Delivery Devices Sales Market Share by Country in 2022
Figure 58. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 59. Europe Pulmonary Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 60. Europe Pulmonary Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 61. Germany Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 70. Egypt Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Pulmonary Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices in 2022
Figure 76. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
Figure 77. Industry Chain Structure of Pulmonary Drug Delivery Devices
Figure 78. Channels of Distribution
Figure 79. Global Pulmonary Drug Delivery Devices Sales Market Forecast by Region (2024-2029)
Figure 80. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報

肺薬物送達装置は、薬剤を肺に直接届けるための装置であり、主に呼吸器疾患の治療に利用されています。近年、医療の進歩とともに、これらのデバイスはますます重要な役割を果たすようになっています。肺薬物送達装置は、特に吸入療法において、効率的な薬剤の届け方として広く用いられています。以下に、肺薬物送達装置の概念、特徴、種類、用途、関連技術などを詳しく説明いたします。

肺薬物送達装置の定義は、主に薬物を肺に直接供給するためのデバイスを指します。これにより、薬剤は迅速に作用し、全身への副作用を軽減することができます。このアプローチは、特に喘息や慢性閉塞性肺疾患（COPD）などの呼吸器疾患の治療に適しています。呼吸器系は、大量の血流を有しているため、薬剤が肺の組織に直接到達しやすく、高い生物利用能を得ることができます。

肺薬物送達装置の特徴には、主に以下の点が挙げられます。まず、吸入による速やかな作用が特徴です。経口薬や注射薬とは異なり、肺に吸入された薬剤は直ちに血流に入るため、迅速な効果を期待できます。次に、高効率である点です。薬剤の一部が消化管を通過する過程で失われることなく、必要な量が直接肺に届きます。また、肺は広い表面積を持つため、薬剤が効率的に吸収され、迅速に気道の炎症を抑えることが可能です。

種類については、主に３つのカテゴリーに分類されます。第一は、定量吸入器（MDI: Metered Dose Inhalers）です。これは、薬剤をエアロゾル状に噴霧し、一定の量を吸入するための装置です。MDIの利点は、使用が簡単で持ち運びやすいことですが、使用方法に注意が必要です。次に、粉末吸入器（DPI: Dry Powder Inhalers）があります。DPIは、乾燥した粉末状の薬剤を吸入するデバイスで、患者が自分自身で吸引することによって薬剤を肺に届けます。最後に、噴霧器（Nebulizers）があります。これは、液体の薬剤を微細な霧として噴霧し、患者がそれを吸入する仕組みです。特に、重症の患者や、適切なタイミングで薬を吸入できない小児に対して有効です。

用途に関して、これらの装置は主に呼吸器疾患の治療に使用されます。喘息の患者は、発作時に迅速に薬を投与する必要があり、吸入器は非常に効果的です。また、COPDの患者も治療に併用されることが多く、維持療法としての重要性が増しています。さらに、肺に直接薬剤を届けることで、全身への影響を抑えられるため、抗生物質や抗ウイルス薬の局所的な治療にも応用されています。

関連技術としては、薬剤の粒子設計やデバイステクノロジーの進歩が挙げられます。粉末吸入器やエアロゾルの設計には、薬剤の粒子サイズや形状が重要であり、これらの特性によって吸入効率が大きく変わります。また、デバイスの使いやすさや携帯性も重要な要素であり、患者の使用体験を向上させるための工夫が求められています。

最後に、肺薬物送達装置の今後の展望について述べます。今後は、より精密で効率的な装置の開発が進むことが期待されています。例えば、ナノ粒子技術を用いた新しい薬剤送達システムや、個別化医療に基づいた吸入療法の進展が考えられます。また、デジタル技術を活用した遠隔モニタリングやデータ収集により、患者の治療効果をリアルタイムで把握できるようになるでしょう。

以上のように、肺薬物送達装置は現代医療において極めて重要な役割を果たしており、その可能性は今後も広がると考えられます。呼吸器疾患の治療において、その恩恵を受ける患者のために、より効果的で安全なデバイスの開発が期待されています。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の肺薬物送達装置市場予測 2023年-2029年(Global Pulmonary Drug Delivery Devices Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の輸液用薬物送達装置市場予測 2023年-2029年
  • 肺ドラッグデリバリーシステムの世界市場2022年～2029年：製品別、用途別、流通チャネル別、地域別
  • 世界の酸素供給装置市場予測 2023年-2029年
  • 世界の鼻腔内治療薬＆ワクチン送達装置市場予測 2023年-2029年
  • 先進的非経口薬物送達装置のグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆